207 related articles for article (PubMed ID: 7678574)
41. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Jeng KS; Sheen IS; Tsai YC
Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
[TBL] [Abstract][Full Text] [Related]
42. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
Sato K; Tanaka M; Kusaba T; Fukuda H; Tanikawa K
Oncol Rep; 1998; 5(2):355-8. PubMed ID: 9468556
[TBL] [Abstract][Full Text] [Related]
44. Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Becker FF; Stillman D; Sell S
Cancer Res; 1977 Mar; 37(3):870-2. PubMed ID: 65218
[TBL] [Abstract][Full Text] [Related]
45. Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Zhou SF; Mo FR; Bin YH; Hou GQ; Xie XX; Luo GR
Clin Biochem; 2011 Mar; 44(4):331-6. PubMed ID: 21047503
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
47. Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.
Saibara T; Maeda T; Miyazaki M; Onishi S; Yamamoto Y
Hepatology; 1993 Aug; 18(2):315-9. PubMed ID: 7687981
[TBL] [Abstract][Full Text] [Related]
48. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
[TBL] [Abstract][Full Text] [Related]
49. [Expression and implication of multidrug resistance associated -protein gene in primary hepatocellular carcinoma].
Wang BL; Chen XP; Zhai SP
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):609-11. PubMed ID: 14572339
[TBL] [Abstract][Full Text] [Related]
50. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
[TBL] [Abstract][Full Text] [Related]
51. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
52. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
53. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Chang YC; Dai YC; Chow NH
Hepatogastroenterology; 2003; 50(53):1637-40. PubMed ID: 14571804
[TBL] [Abstract][Full Text] [Related]
54. Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
Koh T; Taniguchi H; Katoh H; Kunishima S; Yamaguchi A; Yamagishi H
Hepatogastroenterology; 2002; 49(48):1615-8. PubMed ID: 12397748
[TBL] [Abstract][Full Text] [Related]
55. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
56. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Matsumura M; Niwa Y; Kato N; Komatsu Y; Shiina S; Kawabe T; Kawase T; Toyoshima H; Ihori M; Shiratori Y
Hepatology; 1994 Dec; 20(6):1418-25. PubMed ID: 7527002
[TBL] [Abstract][Full Text] [Related]
57. Detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction.
Liu Y; Wu MC; Qian GX; Zhang BH
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):72-6. PubMed ID: 14607627
[TBL] [Abstract][Full Text] [Related]
58. Elevated serum chromogranin A in patients with hepatocellular carcinoma.
Leone N; Pellicano R; Brunello F; Rizzetto M; Ponzetto A
Clin Exp Med; 2002 Nov; 2(3):119-23. PubMed ID: 12447608
[TBL] [Abstract][Full Text] [Related]
59. Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas.
Kuo MT; Iyer B; Wu JR; Lapeyre JN; Becker FF
Cancer Res; 1984 Apr; 44(4):1642-7. PubMed ID: 6200217
[TBL] [Abstract][Full Text] [Related]
60. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
